Clinical Trials Logo

Clinical Trial Summary

Primary immunodeficiencies represent a underdiagnosed group of rare diseases which if diagnosed well and in time can be treated in an efficient manner and prevent complications that may affect the quality of patients life in an severe manner. Neither in Costa Rica nor in Central America studies or national registries regarding the prevalence and characterization of primary immunodeficiencies in adult patients exist up to now. This study reflects for the first time the epidemiologic situation of primary immunodeficiencies in a Central American country, characterizing adult patients diagnosed with primary and idiopathic immune disorders treated in two specialized immunodeficiency clinics in Costa Rica.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04963660
Study type Observational [Patient Registry]
Source Caja Costarricense de Seguro Social
Contact
Status Completed
Phase
Start date November 11, 2018
Completion date November 11, 2019